Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02402699
What this trial is testing

Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan

Who this might be right for
Advanced MelanomaHepatitis BHepatitis C
Bristol-Myers Squibb 3
Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Post-approval studies (Phase 4)Study completedNCT03949764
What this trial is testing

The Kentucky Viral Hepatitis Treatment Study

Who this might be right for
Hepatitis COpioid-Related DisordersInjection Drug Use
Jennifer Havens 374
Not applicableStudy completedNCT05446532
What this trial is testing

Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes

Who this might be right for
Hepatitis B
Corporacion Parc Tauli 120
Testing effectiveness (Phase 2)Study completedNCT00389298
What this trial is testing

A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 36
Post-approval studies (Phase 4)UnknownNCT05177926
What this trial is testing

Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)

Who this might be right for
Hepatitis B, ChronicMother to Child Transmission
Nanfang Hospital, Southern Medical University 330
Testing effectiveness (Phase 2)Study completedNCT00033163
What this trial is testing

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT00926016
What this trial is testing

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Who this might be right for
Chronic Hepatitis C
Brooke Army Medical Center 23
Large-scale testing (Phase 3)Study completedNCT02836249
What this trial is testing

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)

Who this might be right for
HBVChronic HBV Infection
Gilead Sciences 181
Post-approval studies (Phase 4)Study completedNCT01519921
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 150
Not applicableStudy completedNCT03198104
What this trial is testing

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Who this might be right for
Non-alcoholic SteatohepatitisLiver DiseasesLiver Fibroses+2 more
Perspectum 35
Post-approval studies (Phase 4)Study completedNCT02064049
What this trial is testing

Surveillance and Treatment of Prisoners With Hepatitis C

Who this might be right for
Hepatitis C
Kirby Institute 3,692
Large-scale testing (Phase 3)Study completedNCT00697866
What this trial is testing

Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control

Who this might be right for
Hepatitis B
GlaxoSmithKline 951
Not applicableWithdrawnNCT03208322
What this trial is testing

Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02201901
What this trial is testing

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 268
Early research (Phase 1)Study completedNCT01290965
What this trial is testing

Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Scynexis, Inc. 57
Early research (Phase 1)Study completedNCT05561673
What this trial is testing

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Who this might be right for
Hepatitis B
GlaxoSmithKline 122
Early research (Phase 1)Study completedNCT02103569
What this trial is testing

Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 20
Not applicableUnknownNCT06017375
What this trial is testing

Patient Knowledge, Beliefs and Barriers to Hepatitis D Care

Who this might be right for
Hepatitis, Delta
King's College Hospital NHS Trust 113
Early research (Phase 1)WithdrawnNCT05867056
What this trial is testing

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Immunocore Ltd
Next Page